Loading…
Hosted by U.S. Food and Drug Administration, Center for Drug Evaluation and Research · 🇺🇸 US · EN · 20 episodes
Established thought leaders with verified media credentials.
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
U.S. Food and Drug Administration, Center for Drug Evaluation and Research hosts Q&A with FDA, a health show with 20 episodes published.
Q&A with FDA: Recognizing and Reporting Potentially False or Misleading Prescription Drug Promotion with Dr. Catherine Gray
In this episode of the Q&A with FDA podcast, learn about Understanding Drug Recalls with Dr. Ileana Elder in the Office of Compliance.
In this episode of the Q&A with FDA podcast, learn about Utilizing Generic Drug Awareness to Improve Patient Outcomes with Dr. Sarah Ibrahim from FDA’s Office of Generic Drugs.
In this episode of the Q&A with FDA podcast, learn about real world evidence, real world data, and how FDA continues to advance clinical trials and promote reliable evidence to support the safety and effectiveness of dru
Listen to a soundcast of the May 8, 2024, Q&A with FDA: The Role of Artificial Intelligence in Clinical Trial Design and Research with Dr. ElZarrad.
Listen to our latest podcast series, Q&A with FDA, on Switching Between Biosimilars and Their Reference Counterparts, featuring Dr. Sarah Yim.
The Current Status of Oral Phenylephrine as a Nasal Decongestant with Dr. Theresa Michele and Dr. Ilisa Bernstein
Listen to our latest podcast series, Q&A with FDA, on Medication Health Fraud and Avoiding Medication Scams with Cynthia Ng.
Listen to our latest podcast series, Q&A with FDA - FDA’s Regulation of Dietary Supplements featuring Dr. Cara Welch.
Listen to our latest podcast series, Q&A with FDA, on A Step Forward in the Treatment of Opioid and Alcohol Dependence featuring Dr. Iilun Murphy and Dr. Marta Sokolowska.
Navigating the World of Online Pharmacies with CDR Lysette Deshields
Listen to our latest podcast series, Q&A with FDA
FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska
In this podcast series, we answer some of the most frequently asked questions we’ve received from the public.
Generics-at-a-Glance with Dr. Sarah Ibrahim
Expanded Access with Dr. Jacqueline Corrigan-Curay
MedWatch, Your Report Can Make a Difference
FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska
Shedding some light on clinical trials with Dr. Bob Temple
In today’s episode, we’ll be discussing Paxlovid, which is now widely available in community pharmacies.
Catherine Gray
Sunday Times Bestselling Author of The Unexpected Joy of Being Sober, Sunshine Warm Sober, Little Addictions · She Angel Investors
1 appearance on this show
Dr. Heather Stone
associate professor in the College of Education & Human Development · Sage and Stone Homestead
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Q&A with FDA has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Q&A with FDA is hosted by U.S. Food and Drug Administration, Center for Drug Evaluation and Research. The show is categorised under health (fitness) and has published 20 episodes.
Q&A with FDA has published 20 episodes.
Q&A with FDA regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
Q&A with FDA is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Q&A with FDA hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Q&A with FDA average 15 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Q&A with FDA's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched yesterday.